Replies to post #298415 on Innovation Pharmaceuticals Inc (IPIX)

[Jhawker]

It’s very difficult and the testing will take time. Go ipix!
“ A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.”

[KMBJN]

Lots of anecdotal reports of "success" at this time for ivermectin:

https://www.newsmax.com/us/ivermectin-drug-virus/2020/05/22/id/968688/

By David A. Patten | Friday, 22 May 2020 11:16 PM

Reports Friday from multiple trials in the United States and abroad indicate a drug already approved by the FDA to treat parasitic infections is showing “astounding” results, and could represent a breakthrough in efforts to vanquishing the SARS-CoV-2 virus at the heart of the global pandemic.

But as you said possibly poor PK / can't quite get the same doses as reported to be effective in vitro:

https://blogs.sciencemag.org/pipeline/archives/2020/05/11/whats-up-with-ivermectin

So we really need placebo controlled trials.